BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37433700)

  • 21. Serum insulin-like growth factor binding protein-3 as a potential biomarker for diagnosis and prognosis of oesophageal squamous cell carcinoma.
    Luo Y; Hong CQ; Huang BL; Ding TY; Chu LY; Zhang B; Qu QQ; Li XH; Liu CT; Peng YH; Guo HP; Xu YW
    Ann Med; 2022 Dec; 54(1):2153-2166. PubMed ID: 35930383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma.
    Yu J; Wu X; Huang K; Zhu M; Zhang X; Zhang Y; Chen S; Xu X; Zhang Q
    Mol Med Rep; 2019 Jun; 19(6):5309-5320. PubMed ID: 31059058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.
    Dong J; Zeng BH; Xu LH; Wang JY; Li MZ; Zeng MS; Liu WL
    J Transl Med; 2010 Sep; 8():81. PubMed ID: 20813067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a panel of tumor-associated antigens in breast cancer.
    Pagaza-Straffon C; Marchat LA; Herrera L; Díaz-Chávez J; Avante MG; Rodríguez YP; Arreola MC; López-Camarillo C
    Cancer Biomark; 2020; 27(2):207-211. PubMed ID: 31839604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma.
    Ma Y; Qiu C; Wang B; Zhang X; Wang X; Aguilera RJ; Zhang JY
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A RASSF8-AS1 based exosomal lncRNAs panel used for diagnostic and prognostic biomarkers for esophageal squamous cell carcinoma.
    Xie K; Zheng C; Gu W; Jiang Z; Luo C; Luo J; Diao Y; Wang G; Cong Z; Yao X; Hu L; Shen Y
    Thorac Cancer; 2022 Dec; 13(23):3341-3352. PubMed ID: 36266257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody-antigen system.
    Wu J; Wang P; Han Z; Li T; Yi C; Qiu C; Yang Q; Sun G; Dai L; Shi J; Wang K; Ye H
    Cancer Sci; 2022 Feb; 113(2):411-422. PubMed ID: 34821436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment and validation of an immunodiagnostic model for prediction of breast cancer.
    Qiu C; Wang P; Wang B; Shi J; Wang X; Li T; Qin J; Dai L; Ye H; Zhang J
    Oncoimmunology; 2020; 9(1):1682382. PubMed ID: 32002291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunodiagnostic value of combined detection of autoantibodies to tumor-associated antigens as biomarkers in pancreatic cancer.
    Li J; Wang LJ; Ying X; Han SX; Bai E; Zhang Y; Zhu Q
    Scand J Immunol; 2012 Mar; 75(3):342-9. PubMed ID: 22010875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.
    Zhou SL; Ku JW; Fan ZM; Yue WB; Du F; Zhou YF; Liu YL; Li Y; Tang S; Hu YL; Hu XP; Hou ZC; Liu J; Liu Y; Feng XS; Wang LD
    Dis Esophagus; 2015; 28(4):371-9. PubMed ID: 24612004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
    Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
    Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoantibodies as potential biomarkers for the early detection of esophageal squamous cell carcinoma.
    Xu YW; Peng YH; Chen B; Wu ZY; Wu JY; Shen JH; Zheng CP; Wang SH; Guo HP; Li EM; Xu LY
    Am J Gastroenterol; 2014 Jan; 109(1):36-45. PubMed ID: 24296751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling.
    Sudo K; Kato K; Matsuzaki J; Boku N; Abe S; Saito Y; Daiko H; Takizawa S; Aoki Y; Sakamoto H; Niida S; Takeshita F; Fukuda T; Ochiya T
    JAMA Netw Open; 2019 May; 2(5):e194573. PubMed ID: 31125107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and Evaluation of Autoantibody to a Novel Tumor-Associated Antigen GNA11 as a Biomarker in Esophageal Squamous Cell Carcinoma.
    Wang H; Yang X; Sun G; Yang Q; Cui C; Wang X; Ye H; Dai L; Shi J; Zhang J; Wang P
    Front Oncol; 2021; 11():661043. PubMed ID: 34568004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of diagnostic markers and lipid dysregulation in oesophageal squamous cell carcinoma through lipidomic analysis and machine learning.
    Yuan Y; Zhao Z; Xue L; Wang G; Song H; Pang R; Zhou J; Luo J; Song Y; Yin Y
    Br J Cancer; 2021 Aug; 125(3):351-357. PubMed ID: 33953345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovering novel lung cancer associated antigens and the utilization of their autoantibodies in detection of lung cancer.
    Pei L; Liu H; Ouyang S; Zhao C; Liu M; Wang T; Wang P; Ye H; Wang K; Song C; Zhang J; Dai L
    Immunobiology; 2020 Mar; 225(2):151891. PubMed ID: 31839396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.
    Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY
    Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using Serological Proteome Analysis to Identify Serum Anti-Nucleophosmin 1 Autoantibody as a Potential Biomarker in European-American and African-American Patients With Prostate Cancer.
    Dai L; Li J; Xing M; Sanchez TW; Casiano CA; Zhang JY
    Prostate; 2016 Nov; 76(15):1375-86. PubMed ID: 27418398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A panel of autoantibodies against tumor-associated antigens in the early immunodiagnosis of lung cancer.
    Jiang D; Wang Y; Liu M; Si Q; Wang T; Pei L; Wang P; Ye H; Shi J; Wang X; Song C; Wang K; Dai L; Zhang J
    Immunobiology; 2020 Jan; 225(1):151848. PubMed ID: 31980218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantibodies response to MDM2 and p53 in the immunodiagnosis of esophageal squamous cell carcinoma.
    Chai Y; Peng B; Dai L; Qian W; Zhang Y; Zhang JY
    Scand J Immunol; 2014 Nov; 80(5):362-8. PubMed ID: 24965442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.